Skip to content
Screener

Merck & Co. MRK Q1 2025 earnings

Reported April 24, 2025 · Before market open

Revenue$15.5BBeat by $190.1M
EPS$2.22Beat by $0.09
Revenue estimate$15.3B
EPS estimate$2.13

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$17.3B
EPS estimate$2.19

Financials

Q1 2025

Income statement

See full
Revenue$15.5B-1.6%
Gross profit$12.1B-1.0%
Net income$5.1B+6.7%
EPS (diluted)$2.01+7.5%

Balance sheet

See full
Cash & equivalents$8.7B+54.0%
Total debt$36.2B-3.0%
Total equity$48.3B+19.7%
Total assets$115.12B+8.8%

Cash flow

See full
Operating cash flow$2.5B-19.1%
CapEx$1.3B+54.2%
Free cash flow$1.2B-47.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$226.74B-32.2%
Enterprise value$254.17B-30.5%
P/E13×—
P/S3.5×-1.9×

Profitability

See full
Gross margin76.4%+2.1pp
Net margin27.3%—
FCF margin26.7%+7.5pp

Returns & leverage

See full
Return on equity39.3%—
Debt / equity0.7×-0.2×
Current ratio1.4×+0.2×

FAQ

When did Merck & Co. report Q1 2025 earnings?
Merck & Co. (MRK) reported Q1 2025 earnings on April 24, 2025 before market open.
What were Merck & Co.'s Q1 2025 revenue and EPS?
Merck & Co. reported revenue of $15.5B and eps of $2.22 for Q1 2025.
Did Merck & Co. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $15.3B by $190.1M. EPS beat the consensus estimate of $2.13 by $0.09.
How did Merck & Co.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.6% from $15.8B a year earlier and eps grew 7.2% from $2.07.
Where can I find Merck & Co.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-038301) and the 10-Q periodic report (0001628280-25-021834) directly on SEC EDGAR. The filing index links above go to sec.gov.